EUCTR2020-004933-19-SE进行中（未招募）1 期
A Randomized Intervention, Multi-Center Study to Determine the Role of Dexamethasone eye drops against proliferative retinopathy of prematurity - DROPROP
Region Västra Götaland, Sahlgrenska Universitetssjukhuset0 个研究点目标入组 90 人开始时间: 2021年1月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) preterm infants born <30 weeks of gestation
- •2) ROP zone I without plus disease with either
- •a. stage 1 or b. stage 2 or
- •3) ROP posterior zone II without plus disease with either
- •a.Posterior ROP stage 2
- •b. ROP stage 3 with or without notch in zone I
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 100
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) Ocular infection
- •2) If the patient is judged unsuitable for the study by treating neonatologist/paediatrician or ophthalmologist for any other reason
研究者
相似试验
招募中
1 期
A Randomized Intervention, Multi-Center Study to Determine the Role of Dexamethasone eye drops against proliferative retinopathy of prematurityRetinopathy of PrematurityCTIS2023-505318-97-00Vaestra Goetalandsregionen100
招募中
Unknown
A Multicenter Prospective Randomized Interventional Study Examining the Impact of Wide Interlesion Distance in High Power Short Duration Atrial Fibrillation Ablation Using the TactiFlexAtrial fibrillationJPRN-jRCT1042230052aruse Yoshihisa204
已完成
不适用
GIVE UP FOR GOOD- A study to evaluate the effectiveness of a pharmacist-led multidisciplinary smoking cessation intervention for smokers admitted to public hospitals.Tobacco use and dependenceSmoking CessationPublic Health - Health service researchMental Health - AddictionACTRN12612000368831Monash University600
进行中（未招募）
1 期
A Randomized Study to Determine the Effect of Triheptanoin in Pediatric Patients with Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)CTIS2023-509809-76-00ltragenyx Pharmaceutical Inc.70
进行中（未招募）
1 期
A Randomized, Double-blind, Multicenter Study to Demonstrate Equivalent Efficacy and to Compare Safety and Immunogenicity of a Biosimilar Ustekinumab (AVT04) and Stelara® in Patients With Moderate to Severe Chronic Plaque-type PsoriasisEUCTR2020-004493-22-PLAlvotech Swiss AG528